I keep an eye on these types of treatments. Type 1 diabetes being autoimmune and all.
So far, I’m putting it in the bucket with all the other “cure is just 5 years away” things we hear about.
It’s promising, and neat it’s worked in these cases, but I remain skeptical. Twice over as it appears to be research from China, who doesn’t have the best track record for robust scientific integrity. We’ll see how repeatable this stuff is soon enough.
I’m right there with you. I’d love to see the dream of the decentralized media return, but it’s long-dead. The “Normal” user doesn’t give a fuck about the benefits and even the moderate barrier to entry over some centralized platform is enough to keep them away.
Tech-minded people seem to often forget that even the most simplistic choices like “Choose an instance” is a big deal for people. The platform that’s the most familiar, and easiest to use is going to be the one that wins, and, right now, that looks like it’s Bluesky.